Inmed Pharmaceuticals Inc Asset Turnover Ratio (INM), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Inmed Pharmaceuticals Inc  (NASDAQ: INM)
 

Inmed Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Mar 31 2026, Inmed Pharmaceuticals Inc has not recorded any assets.
Visit Inmed Pharmaceuticals Inc Balance sheet

Within sector Inmed Pharmaceuticals Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition



INM Asset Turnover Ratio (Mar 31 2026)
III. Quarter
(Dec 31 2025)
II. Quarter
(Sep 30 2025)
I. Quarter
(Jun 30 2025)
IV. Quarter
(Mar 31 2025)
III. Quarter
Y / Y Asset Change -13.09 % 15.73 % 27.38 % 15.66 % -21.87 %
Y / Y Revenue Change - -26.22 % -11.43 % 48.7 % 7.59 %
Asset Turnover Ratio (TTM) - 0.23 0.25 0.27 0.26
INM's Total Ranking # # # # #
Seq. Asset Change -18.55 % -16.45 % -69.52 % 318.99 % 8.45 %
Seq. Revenue Change - -26.77 % -14.15 % 3.41 % 13.48 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Indivior Pharmaceuticals Inc   0.98 $ 1,292.000  Millions$ 1,316.500  Millions
Yunhong Green Cti Ltd   0.98 $ 21.740  Millions$ 22.254  Millions
Pacs Group Inc   0.97 $ 5,432.276  Millions$ 5,594.153  Millions
Caredx Inc   0.97 $ 412.820  Millions$ 425.214  Millions
Orthofix Medical Inc   0.97 $ 824.944  Millions$ 851.754  Millions
Trisalus Life Sciences Inc   0.96 $ 44.183  Millions$ 46.023  Millions
Nexgel Inc   0.96 $ 10.382  Millions$ 10.848  Millions
Embecta Corp   0.96 $ 1,043.100  Millions$ 1,092.100  Millions
Travere Therapeutics Inc   0.95 $ 536.195  Millions$ 563.567  Millions
Neuropace Inc   0.95 $ 98.926  Millions$ 104.458  Millions
Select Medical Holdings Corp  0.95 $ 5,521.134  Millions$ 5,830.411  Millions
Omada Health Inc   0.94 $ 281.916  Millions$ 299.661  Millions
Regen Biopharma Inc   0.94 $ 0.237  Millions$ 0.252  Millions
Corcept Therapeutics Inc  0.94 $ 769.096  Millions$ 819.215  Millions
Madrigal Pharmaceuticals Inc   0.93 $ 1,132.490  Millions$ 1,216.189  Millions
Ufp Technologies Inc   0.93 $ 608.621  Millions$ 654.310  Millions
Accuray Incorporated  0.93 $ 427.893  Millions$ 461.224  Millions
Community Health Systems Inc   0.92 $ 12,291.000  Millions$ 13,316.000  Millions
Ironwood Pharmaceuticals inc   0.92 $ 361.514  Millions$ 392.619  Millions
Insulet Corporation  0.92 $ 2,900.800  Millions$ 3,169.025  Millions
Liquidia Corporation  0.91 $ 288.065  Millions$ 315.715  Millions
Apyx Medical Corp  0.90 $ 55.304  Millions$ 61.355  Millions
Cue Biopharma Inc   0.90 $ 32.731  Millions$ 36.360  Millions
Pediatrix Medical Group Inc   0.90 $ 1,931.686  Millions$ 2,154.624  Millions
Verrica Pharmaceuticals Inc   0.90 $ 37.161  Millions$ 41.480  Millions
Genedx Holdings Corp   0.89 $ 442.908  Millions$ 496.944  Millions
Lakeland Industries Inc   0.89 $ 193.318  Millions$ 217.323  Millions
Enhabit Inc   0.89 $ 1,064.900  Millions$ 1,199.925  Millions
Protalix Biotherapeutics inc   0.88 $ 76.381  Millions$ 86.358  Millions
Teladoc Health Inc   0.88 $ 2,514.453  Millions$ 2,859.528  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.